Pfizer Inc. (BIT:1PFE)

Market Cap	121.21B
Revenue (ttm)	54.48B
Net Income (ttm)	9.18B
Shares Out	n/a
EPS (ttm)	1.62
PE Ratio	13.21
Forward PE	8.96
Dividend	1.55 (7.20%)
Ex-Dividend Date	Jul 24, 2025

Volume	5,837
Average Volume	9,219
Open	21.93
Previous Close	21.90
Day's Range	21.51 - 22.00
52-Week Range	18.73 - 27.50
Beta	n/a
RSI	49.76
Earnings Date	Nov 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Pharmaceutical Preparations
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD